Aminomethylbenzoic acid may be useful as an antifibrinolytic agent A174994.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Alpha-1-proteinase inhibitor | Alpha-1-proteinase inhibitor may increase the thrombogenic activities of Aminomethylbenzoic acid. |
| Menadione | Menadione may increase the thrombogenic activities of Aminomethylbenzoic acid. |
| Tranexamic acid | Tranexamic acid may increase the thrombogenic activities of Aminomethylbenzoic acid. |
| Aminocaproic acid | Aminocaproic acid may increase the thrombogenic activities of Aminomethylbenzoic acid. |
| Aprotinin | Aprotinin may increase the thrombogenic activities of Aminomethylbenzoic acid. |
| Hydrogen peroxide | Hydrogen peroxide may increase the thrombogenic activities of Aminomethylbenzoic acid. |
| Camostat | Aminomethylbenzoic acid may increase the thrombogenic activities of Camostat. |
| Menadione bisulfite | Aminomethylbenzoic acid may increase the thrombogenic activities of Menadione bisulfite. |
| Fibrinogen human | The therapeutic efficacy of Fibrinogen human can be increased when used in combination with Aminomethylbenzoic acid. |
| Tretinoin | The risk or severity of Thrombosis can be increased when Aminomethylbenzoic acid is combined with Tretinoin. |
| Antihemophilic factor, human recombinant | Aminomethylbenzoic acid may increase the thrombogenic activities of Antihemophilic factor, human recombinant. |
| Coagulation factor VIIa Recombinant Human | Aminomethylbenzoic acid may increase the thrombogenic activities of Coagulation factor VIIa Recombinant Human. |
| Coagulation Factor IX (Recombinant) | Aminomethylbenzoic acid may increase the thrombogenic activities of Coagulation Factor IX (Recombinant). |
| Calcium | Aminomethylbenzoic acid may increase the thrombogenic activities of Calcium. |
| Pantothenic acid | Aminomethylbenzoic acid may increase the thrombogenic activities of Pantothenic acid. |
| Formic acid | Aminomethylbenzoic acid may increase the thrombogenic activities of Formic acid. |
| Platelet Activating Factor | Aminomethylbenzoic acid may increase the thrombogenic activities of Platelet Activating Factor. |
| Turoctocog alfa | Aminomethylbenzoic acid may increase the thrombogenic activities of Turoctocog alfa. |
| Catridecacog | Aminomethylbenzoic acid may increase the thrombogenic activities of Catridecacog. |
| Antihemophilic factor (recombinant), PEGylated | Aminomethylbenzoic acid may increase the thrombogenic activities of Antihemophilic factor (recombinant), PEGylated. |
| Prothrombin | Aminomethylbenzoic acid may increase the thrombogenic activities of Prothrombin. |
| Factor IX Complex (Human) | Aminomethylbenzoic acid may increase the thrombogenic activities of Factor IX Complex (Human). |
| Susoctocog alfa | Aminomethylbenzoic acid may increase the thrombogenic activities of Susoctocog alfa. |
| Eftrenonacog alfa | Aminomethylbenzoic acid may increase the thrombogenic activities of Eftrenonacog alfa. |
| Rusalatide acetate | Aminomethylbenzoic acid may increase the thrombogenic activities of Rusalatide acetate. |
| Vatreptacog alfa | Aminomethylbenzoic acid may increase the thrombogenic activities of Vatreptacog alfa. |
| Factor XIII (human) | Aminomethylbenzoic acid may increase the thrombogenic activities of Factor XIII (human). |
| Von Willebrand factor human | Aminomethylbenzoic acid may increase the thrombogenic activities of Von Willebrand factor human. |
| Coagulation factor X human | Aminomethylbenzoic acid may increase the thrombogenic activities of Coagulation factor X human. |
| Coagulation factor VII human | Aminomethylbenzoic acid may increase the thrombogenic activities of Coagulation factor VII human. |
| Anti-inhibitor coagulant complex | Aminomethylbenzoic acid may increase the thrombogenic activities of Anti-inhibitor coagulant complex. |
| Coagulation Factor IX Human | Aminomethylbenzoic acid may increase the thrombogenic activities of Coagulation Factor IX Human. |
| Antihemophilic factor human | Aminomethylbenzoic acid may increase the thrombogenic activities of Antihemophilic factor human. |
| Kallidinogenase | Aminomethylbenzoic acid may increase the thrombogenic activities of Kallidinogenase. |
| Trenonacog alfa | Aminomethylbenzoic acid may increase the thrombogenic activities of Trenonacog alfa. |
| Albutrepenonacog alfa | Aminomethylbenzoic acid may increase the thrombogenic activities of Albutrepenonacog alfa. |
| Emicizumab | Aminomethylbenzoic acid may increase the thrombogenic activities of Emicizumab. |
| Nonacog beta pegol | Aminomethylbenzoic acid may increase the thrombogenic activities of Nonacog beta pegol. |
| Moroctocog alfa | Aminomethylbenzoic acid may increase the thrombogenic activities of Moroctocog alfa. |
| Beroctocog alfa | Aminomethylbenzoic acid may increase the thrombogenic activities of Beroctocog alfa. |
| Andexanet alfa | Aminomethylbenzoic acid may increase the thrombogenic activities of Andexanet alfa. |
| Calcium cation | Aminomethylbenzoic acid may increase the thrombogenic activities of Calcium cation. |
| Damoctocog alfa pegol | Aminomethylbenzoic acid may increase the thrombogenic activities of Damoctocog alfa pegol. |
| Turoctocog alfa pegol | Aminomethylbenzoic acid may increase the thrombogenic activities of Turoctocog alfa pegol. |
| Alteplase | The therapeutic efficacy of Aminomethylbenzoic acid can be decreased when used in combination with Alteplase. |
| Urokinase | The therapeutic efficacy of Aminomethylbenzoic acid can be decreased when used in combination with Urokinase. |
| Reteplase | The therapeutic efficacy of Aminomethylbenzoic acid can be decreased when used in combination with Reteplase. |
| Anistreplase | The therapeutic efficacy of Aminomethylbenzoic acid can be decreased when used in combination with Anistreplase. |
| Tenecteplase | The therapeutic efficacy of Aminomethylbenzoic acid can be decreased when used in combination with Tenecteplase. |
| Streptokinase | The therapeutic efficacy of Aminomethylbenzoic acid can be decreased when used in combination with Streptokinase. |
| Lanoteplase | The therapeutic efficacy of Aminomethylbenzoic acid can be decreased when used in combination with Lanoteplase. |
| Amediplase | The therapeutic efficacy of Aminomethylbenzoic acid can be decreased when used in combination with Amediplase. |
| Saruplase | The therapeutic efficacy of Aminomethylbenzoic acid can be decreased when used in combination with Saruplase. |
| Protein S human | Aminomethylbenzoic acid may increase the thrombogenic activities of Protein S human. |
| Rurioctocog alfa pegol | Aminomethylbenzoic acid may increase the thrombogenic activities of Rurioctocog alfa pegol. |
| Etranacogene dezaparvovec | Aminomethylbenzoic acid may increase the thrombogenic activities of Etranacogene dezaparvovec. |